Stryker SYK Orthopaedics — Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Stryker in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Stryker’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Stryker's orthopaedics — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Stryker's orthopaedics — revenue?
- Stryker (SYK) reported orthopaedics — revenue of $2.81B in Q1 2026.
- How has Stryker's orthopaedics — revenue changed year-over-year?
- Stryker's orthopaedics — revenue increased by 0.1% year-over-year, from $2.81B to $2.81B.
- What is the long-term trend for Stryker's orthopaedics — revenue?
- Over 3 years (2022 to 2025), Stryker's orthopaedics — revenue has grown at a 9.5% compound annual growth rate (CAGR), from $7.56B to $9.92B.
- What does orthopaedics — revenue mean?
- This metric represents the total gross revenue generated by the sale of orthopedic products, including reconstructive implants, surgical instruments, and related medical devices. It reflects the market demand for the company's core musculoskeletal solutions and serves as a primary indicator of the segment's competitive position within the global medical device industry. Growth in this area is typically driven by surgical volume, new product innovation, and expansion into emerging clinical applications.